Julie B. Milstien - Concepedia

Author

Julie B. Milstien

Also Known As

J B Milstien, J Milstien, J. B. Milstien, J. Milstien, J.B Milstien, J.B. Milstien, JULIE B. MILSTIEN, Julie B Milstien, Julie B. Milstien, Julie Milstien

104

Publications

2.8K

Citations

H-Index

133

Concepts

All Affiliations

World Health Organization Center for Biologics Evaluation and Research National Institutes of Health University of Maryland, Baltimore National Institute for Biological Standards and Control

About

Julie B. Milstien is an author at World Health Organization specializing in medicine, vaccination, and vaccine safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	36	1.4K
2	Engineering	7	7	144
3	Health Sciences	2	2	62
4	Business	1	1	25
5	Education	1	1	37

Julie B. Milstien

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Paralytic poliomyelitis: seasoned strategies, disappearing disease Harry F. Hull, N. A. Ward, B. Hull, The Lancet MedicineDisease OutbreakSeasoned StrategiesPolio	1994	235
Characterization of WiDr: A human colon carcinoma cell line P. Noguchi, R. E. Wallace, J.H. Johnson, In Vitro Cellular & Developmental Biology - Plant MedicineColorectal CancerPathologyMolecular PathologyCancer Biology	1979	171
Characterization of Murine Leukaemia Virus-specific DNA present in Normal Mouse Cells Lawrence D. Gelb, Julie B. Milstien, Malcolm A. Martin, Nature New Biology MedicinePathologyDna ReplicationVirologyVirus Gene	1973	109
Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Vance Dietz, Julie B. Milstien, F. van Loon, PubMed	1996	82
Ensuring vaccine safety in immunization programmes — a WHO perspective Luis Jódar, Philippe Duclos, Julie B. Milstien, Vaccine VaccinationVaccine SafetyVaccinologyPreventive MedicineVaccine Development	2001	75
Access to vaccine technologies in developing countries: Brazil and India Julie B. Milstien, Patrick Gaulé, Miloud Kaddar Vaccine VaccinationVaccinologyVaccine SafetyPreventive MedicineVaccine Development	2007	52
An Oligonucleotide Affinity Column for RNA-Dependent DNA Polymerase from RNA Tumor Viruses Brenda I. Gerwin, Julie B. Milstien Proceedings of the National Academy of Sciences	1972	52
Factors Affecting Physician Reporting of Adverse Drug Reactions Julie B. Milstien, Gerald A. Faich, John Hsu, Drug Information Journal Drug HypersensitivityPhysician ReportingAdverse EventPatient SafetyOutcomes Research	1986	52
New challenges in assuring vaccine quality. Nora Dellepiane, Elwyn Griffiths, Julie B. Milstien PubMed Vaccine RegulationImmunologyInfluenza VaccinesCross-protectionVaccine Surveillance	2000	47
Development of New Tuberculosis Vaccines: A Global Perspective on Regulatory Issues Michael J. Brennan, Uli Fruth, Julie B. Milstien, PLoS Medicine	2007	46

Page 1